Jaffetilchin Investment Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,610
Closed -$323K 386
2018
Q3
$323K Buy
+3,610
New +$319K 0.07% 222
2017
Q4
Sell
-6,567
Closed -$958K 319
2017
Q3
$958K Buy
+6,567
New +$894K 0.23% 77
2017
Q2
Sell
-3,045
Closed -$379K 312
2017
Q1
$379K Buy
3,045
+160
+6% +$19.1K 0.1% 172
2016
Q4
$334K Buy
+2,885
New +$321K 0.1% 173
2015
Q2
Sell
-3,852
Closed -$444K 260
2015
Q1
$444K Sell
3,852
-30
-0.8% -$3.58K 0.13% 121
2014
Q4
$434K Sell
3,882
-6,037
-61% -$637K 0.15% 104
2014
Q3
$940K Buy
9,919
+4,892
+97% +$441K 0.34% 39
2014
Q2
$432K Sell
5,027
-171
-3% -$13K 0.15% 105
2014
Q1
$363K Sell
5,198
-4,568
-47% -$362K 0.14% 112
2013
Q4
$825K Sell
9,766
-424
-4% -$33.5K 0.41% 49
2013
Q3
$785K Buy
10,190
+3,318
+48% +$233K 0.46% 49
2013
Q2
$402K Buy
+6,872
New +$414K 0.28% 99

Other funds holding CELG

Jaffetilchin Investment Partners's CELG Position: Q4 2018 in Review

Jaffetilchin Investment Partners sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 3,610 shares — an estimated $323K sold.

Jaffetilchin Investment Partners first reported a position in CELG in Q2 2013 and held it in 12 quarters. The position peaked at $958K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Jaffetilchin Investment Partners reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 3,610 Celgene Corp shares in Q4 2018, an estimated $323K.
  • Jaffetilchin Investment Partners first reported a position in Celgene Corp in Q2 2013 and held it in 12 quarters.
  • Jaffetilchin Investment Partners's Celgene Corp position peaked at $958K in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2018, filed 11 Feb 2019.